Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome
- PMID: 22929411
- DOI: 10.1016/j.cyto.2012.07.038
Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome
Abstract
Proinflammatory cytokines are related to the pathogenesis of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic-uremic syndrome (HUS). We assessed the kinetics of the release of cytokines such as neopterin, interleukin (IL)-6, IL-8 and tumour necrosis factor (TNF)-α and the soluble forms of type I and II TNF receptors during EHEC O111-induced HUS (EHEC O111/HUS). Fourteen patients with EHEC O111/HUS were enrolled in this study. Serum concentrations of all cytokines other than TNF-α were significantly elevated in patients with severe HUS compared with those in patients with mild HUS. Although serum concentrations of TNF-α were not significantly higher in patients with severe HUS, most patients with acute encephalopathy showed elevated TNF-α levels. Serum concentrations of these cytokines rapidly and markedly increased, and massive hypercytokinaemia developed 1 day before the diagnosis of HUS in patients with severe HUS. Changes in the number of white blood cells and concentration of serum lactate dehydrogenase were significantly larger between the onset of hemorrhagic colitis and the time of the diagnosis of HUS in patients with severe HUS compared with those in patients with mild HUS. Proinflammatory cytokines play an important role in the pathogenesis of EHEC infection and development of severe complications, including HUS and encephalopathy. Monitoring the cytokine profile may be useful for assessing disease activity of EHEC O111 infections.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.J Neuroimmunol. 2008 May 30;196(1-2):147-52. doi: 10.1016/j.jneuroim.2008.02.012. Epub 2008 Apr 14. J Neuroimmunol. 2008. PMID: 18410971
-
Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.Neurochem Int. 2015 Jun-Jul;85-86:24-30. doi: 10.1016/j.neuint.2015.04.003. Epub 2015 Apr 17. Neurochem Int. 2015. PMID: 25895963
-
Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome.Cytokine. 2014 Mar;66(1):1-6. doi: 10.1016/j.cyto.2013.12.005. Epub 2013 Dec 31. Cytokine. 2014. PMID: 24548418
-
Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS.Pediatr Int. 2020 Mar;62(3):308-315. doi: 10.1111/ped.14053. Epub 2020 Jan 22. Pediatr Int. 2020. PMID: 31742829 Review.
-
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].Wien Klin Wochenschr. 1997 Sep 19;109(17):669-77. Wien Klin Wochenschr. 1997. PMID: 9381722 Review. German.
Cited by
-
Serum insulin-like growth factor-binding protein 2 levels as an indicator for disease severity in enterohemorrhagic Escherichia coli induced hemolytic uremic syndrome.Ren Fail. 2021 Dec;43(1):382-387. doi: 10.1080/0886022X.2021.1885445. Ren Fail. 2021. PMID: 33641616 Free PMC article.
-
Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.Clin Exp Nephrol. 2017 Feb;21(1):76-82. doi: 10.1007/s10157-016-1254-z. Epub 2016 Mar 5. Clin Exp Nephrol. 2017. PMID: 26945868
-
Characterization of enterohemorrhagic Escherichia coli O111 and O157 strains isolated from outbreak patients in Japan.J Clin Microbiol. 2014 Aug;52(8):2757-63. doi: 10.1128/JCM.00420-14. Epub 2014 May 14. J Clin Microbiol. 2014. PMID: 24829231 Free PMC article.
-
Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.Clin Exp Nephrol. 2017 Dec;21(6):1083-1087. doi: 10.1007/s10157-017-1391-z. Epub 2017 Mar 10. Clin Exp Nephrol. 2017. PMID: 28283851
-
Guidelines for the management and investigation of hemolytic uremic syndrome.Clin Exp Nephrol. 2014 Aug;18(4):525-57. doi: 10.1007/s10157-014-0995-9. Clin Exp Nephrol. 2014. PMID: 25099085 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical